Navigation Links
E-prescribing of Controlled Substances Moves Real-Time Prescription Drug Monitoring Toward Reality
Date:7/7/2008

LEXINGTON, Ky., July 7 /PRNewswire-FirstCall/ -- VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) the owners of Veriscrip(TM) the nation's only proven Real-Time Prescription Monitoring System announced it's support today of a proposed rule that would allow for the electronic prescribing of controlled substances.

June 27th, the Drug Enforcement Administration proposed regulations that would allow physicians to electronically prescribe controlled substances. Current rules bar e-prescriptions for controlled substances, classified as medications that have the potential for abuse or addiction. Controlled substances account for between 10% and 13% of all U.S. prescriptions. The DEA hopes to reduce prescription forgery by creating a "closed system of controls on controlled-substances dispensing." In a separate initiative the House recently approved a bill (HR 6331) that would provide an incentive to physicians to use e-prescribing that would sharply increase its adoption.

According to Jim Renfro, President of VHGI, "Both of these recent events are very exciting for Veriscrip because they are key factors in facilitating the use of e-prescribing in real-time Prescription Drug Monitoring. From the beginning our company has stressed the importance of tracking controlled substances from their inception electronically." Renfro goes on further to say, "I am confident that once these rules are put into effect, you will begin to see more local and state governments moving more aggressively to curtail the misuse and major abuse of prescription drugs in a real time manner. I think we have positioned Veriscrip to be a leader in this effort and to take full advantage of the potential new business, which will result from this rule change."

This press release contains forward-looking statements that reflect the Company's current expectations regarding future events. While these statements reflect the Company's best current judgment, they are subject to risks and uncertainties. Actual results may differ significantly from projected results due to a number of factors, including, but not limited to assumptions, beliefs and opinions relating to the business and growth strategy of VirtualHealth Technologies, Inc. and its wholly owned subsidiaries Verified Prescription Safeguards, Inc., VPS Holding, LLC, Envoii Healthcare, LLC, Medical Office Software, Inc. and implementation thereof, based upon the Company's interpretation and analysis of financial and market conditions, the decisions of businesses with whom the Company is either engaged in business with or negotiating, healthcare industry trends and management's ability to successfully finance, develop, market, sell and implement its e-commerce and internet solutions, clinical and financial e-transaction services and software applications to physicians, pharmacies, governmental agencies, laboratories, insurance companies, HMOs, and payers. These factors and other risk factors are more fully discussed in the Company's filings with the Securities and Exchange Commission. The Company expressly disclaims any intent or obligation to update any forward-looking statements.

Contact: Shareholder Relations

VirtualHealth Technologies, Inc.

325 West Main Street, Suite 240

Lexington, KY 40507

(859) 455-9255

Email: Shareholder.Relations@virtualhealthtechnologies.com

Website: http://www.virtualhealthtechnologies.com


'/>"/>
SOURCE VirtualHealth Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Zix Corporation Issues Statement Supporting Bipartisan Push for Medicare e-Prescribing Requirement
2. L.A. Care Offers ZixCorp e-Prescribing Services Through Health I.T. Incentive Program
3. PCMAs New Ad Campaign: E-Prescribing is Ready Now
4. Consumers, Businesses, Unions, and Medical Professionals: Time for Congress to Act on E-Prescribing Legislation
5. CMS Releases Final E-Prescribing Standards in Medicare
6. Zix Corporation Celebrates National Patient Safety Awareness Week with Continued Success in e-Prescribing
7. PCMA Applauds Secretary Leavitts Support for Requiring E-Prescribing in Medicare
8. PCMA: 2008 Health Debate Highlights Workable Solutions Like E-Prescribing
9. PCMA 2008 Agenda: Support E-Prescribing, Biogenerics; Oppose Bills that Increase Costs
10. One Thing Washington Can Agree On: Time for E-Prescribing in Medicare
11. PCMA Supports Bipartisan Legislation Calling for E-Prescribing Requirement in Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps ... fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... Bill ... management industry in the coastal communities. After Tina Howe joined the team, the Bill ... happy employees, honest services at affordable rates, and giving back to the San Diego ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... -- The Global Effective Microorganisms (EM) Market by ... covered and analysed the potential of Global Effective Microorganisms (EM) ... and growth factors. The report identifies and analyses the emerging ... global market. ... Tables and Figures, 6 Major Company Profiles, spread across 124 ...
Breaking Medicine Technology: